NCT00506961View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Diabetes MellitusDyslipidemia
Interventions
DRUG

Rosuvastatin

10 mg rosuvastatin for 4 weeks followed by rosuvastatin or another 12 weeks

DRUG

Simvastatin

20 mg simvastatin for 4 weeks followed by 40 mg simvastatin for another 8 weeks

Trial Locations (2)

Unknown

Taichung Veterans General Hospital, Taichung

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

NCT00506961 - Evaluate the Efficacy and Safety of Rosuvastatin Versus Simvastatin in Type 2 Diabetic Patients With Dyslipidemia | Biotech Hunter | Biotech Hunter